肿瘤相关成纤维细胞通过分泌SDF-1调节肺癌细胞系A549的化疗耐药性
本研究探讨肿瘤相关成纤维细胞(CAF)是否通过分泌基质细胞衍生因子1(SDF-1)调节肺癌A549细胞的化疗耐药性。采用原代细胞分离获得肺癌患者CAF,用MTT法、荧光定量PCR、Western blot和ELISA检测。结果显示CAF通过SDF-1/CXCR4轴上调Bcl-xL表达,增强A549细胞对顺铂的耐药性。
要点
- CAF促进A549细胞增殖,正常成纤维细胞(NF)对增殖影响不明显。
- CAF上清组A549细胞Bcl-xL mRNA和蛋白表达均高于NF上清组。
- CAF分泌SDF-1高于NF,AMD3100可部分逆转CAF上清引起的耐药。
核心结论
- CAF通过分泌SDF-1激活肺癌A549细胞中的趋化因子受体4(CXCR4),提高Bcl-xL的表达,增强肺癌A549细胞对顺铂的化疗耐药性,为CAF作为肺癌潜在治疗靶点提供了实验依据。
研究设计与样本
- 采用原代细胞分离技术从肺癌患者获得CAF,以正常成纤维细胞(NF)为对照,用MTT法检测A549细胞增殖和化疗耐药性,荧光定量PCR检测Bcl-xL mRNA,Western blot检测Bcl-xL蛋白,ELISA检测SDF-1分泌。
主要发现
- 培养72 h后,A549+CAF上清组吸光度值为0.814±0.006,A549+NF上清组为0.753±0.006,差异有统计学意义(P<0.05)。
- A549组、A549+NF上清组和A549+CAF上清组的Bcl-xL mRNA表达水平分别为1.00±0.11、1.10±0.09和3.50±0.30,A549+CAF上清组与A549+NF上清组比较差异有统计学意义(P<0.05)。
- A549组、A549+NF上清组和A549+CAF上清组的Bcl-xL蛋白表达水平分别为1.00±0.08、1.10±0.12和3.10±0.25,A549+CAF上清组与A549+NF上清组比较差异有统计学意义(P<0.05)。
- A549+NF上清组和A549+CAF上清组中SDF-1含量分别为3.23±0.02和9.53±0.10,差异有统计学意义(P<0.05)。
- A549组、A549+AMD3100组、A549+NF上清组、A549+NF上清+AMD3100组、A549+CAF上清组和A549+CAF上清+AMD3100组的吸光度值分别为0.43±0.03、0.25±0.02、0.48±0.03、0.31±0.03、0.72±0.06和0.45±0.03,A549+CAF上清组与A549+NF上清组比较差异有统计学意义(P<0.05)。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate whether cancer-associated- fibroblasts (CAF), the key component of tumor microenvironment, regulate the chemoresistant capacity of lung cancer cell line A549 through SDF-1 secretion. Methods: Primary cell isolation techniques was used to isolate cancer-associated-fibroblasts from lung cancer patients. MTT assay was applied to determine the proliferation and chemoresistance of A549 cells. Quantative PCR was used to detect the mRNA changes of Bcl-xL. Western blotting was used to detect the protein expression of Bcl-xL. ELISA was applied to detect the SDF-1 secretion from normal fibroblasts (NF) and CAF. Results: CAF promoted the proliferation of A549 cells, while NF had no significant effect on them. After 72 hrs incubation, the absorbance value of A549+ CAF medium group was 0.814±0.006, significantly different from the 0.753±0.006 of the A549+ NF medium group (P<0.05). The Q-PCR assay indicated that mRNA expressions of Bcl-xL in the A549 group, A549+ NF medium group and A549+ CAF medium group were 1.00±0.11, 1.10±0.09 and 3.50±0.30, respectively, showing a significant difference between the A549+ NF medium group and A549+ CAF medium group (P<0.05). The Western blot showed that protein expressions of Bcl-xL in the A549 group, A549+ NF medium group and A549+ CAF medium group were 1.00±0.08, 1.10±0.12 and 3.10±0.25, respectively, with a significant difference between the A549+ NF medium group and A549+ CAF medium group (P<0.05). The ELISA results showed that the SDF-1 concentrations in the A549+ NF medium group and A549+ CAF medium group were 3.23±0.02 and 9.53±0.10, respectively, significantly different from each other (P<0.05). The MTT assay indicated that the absorbance values of OD of A549 group, A549+ AMD3100 group, A549+ NF medium group, A549+ NF medium+ AMD3100 group, A549+ CAF medium and A549+ CA Fmedium+ AMD3100 group were 0.43±0.03, 0.25±0.02, 0.48±0.03, 0.31±0.03, 0.72±0.06 and 0.45±0.03, respectively. The data of A549+ NF medium group was significantly different from that of A549+ CAF medium group (P<0.05). Conclusions: Cancer-associated-fibroblasts enhance the drug resistance of A549 cells through SDF-1 secretion, upregulating the expression level of Bcl-xL through interaction with CXCR4. Our study not only illustrates that tumor microenvironment is able to enhance drug resistance of tumor, but also provides experimental evidence for the cancer-associated-fibroblasts as a potential therapeutic target for the treatment of lung cancer. 目的: 探讨肿瘤相关成纤维细胞(CAF)是否通过分泌基质细胞衍生因子1(SDF-1)调节肺癌A549细胞的化疗耐药性。 方法: 采用原代细胞分离方法获得肺癌患者的CAF,采用四甲基偶氮唑蓝(MTT)法检测A549细胞的增殖能力和对化疗药物的耐药性,荧光定量PCR检测Bcl-xL mRNA水平,Western blot检测Bcl-xL蛋白水平,酶联免疫吸附试验(ELISA)检测CAF分泌SDF-1的情况。 结果: CAF可以促进肺癌A549细胞的增殖,而正常纤维细胞对A549细胞增殖的影响不明显。培养72 h后,A549+CAF上清组和A549+NF上清组的吸光度(A)值分别为0.814±0.006和0.753±0.006,差异有统计学意义(P<0.05)。荧光定量PCR检测结果显示,A549组、A549+NF上清组和A549+CAF上清组的Bcl-xL mRNA表达水平分别为1.00±0.11、1.10±0.09和3.50±0.30,A549+CAF上清组与A549+NF上清组比较,差异有统计学意义(P<0.05)。Western blot检测显示,A549组、A549+NF上清组和A549+CAF上清组的Bcl-xL蛋白表达水平分别为1.00±0.08、1.10±0.12和3.10±0.25,A549+CAF上清组与A549+NF上清组比较,差异有统计学意义(P<0.05)。ELISA检测显示,A549+NF上清组和A549+CAF上清组中SDF-1含量分别为3.23±0.02和9.53±0.10,差异有统计学意义(P<0.05)。MTT检测显示,A549组、A549+AMD3100组、A549+NF上清组、A549+NF上清+AMD3100组、A549+CAF上清组和A549+CAF上清+AMD3100组的A值分别为0.43±0.03、0.25±0.02、0.48±0.03、0.31±0.03、0.72±0.06和0.45±0.03,A549+CAF上清和A549+NF上清组比较,差异有统计学意义(P<0.05)。 结论: CAF通过分泌SDF-1激活肺癌A549细胞中的趋化因子受体4(CXCR4),提高Bcl-xL的表达,增强肺癌A549细胞对顺铂的化疗耐药性,这为CAF作为肺癌潜在的治疗靶点提供了实验依据。.
引用
- Zou F, Zhang ZH, Zhang YT, et al. [Cancer-associated-fibroblasts regulate the chemoresistance of lung cancer cell line A549 via SDF-1 secretion]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28535649. doi:10.3760/cma.j.issn.0253-3766.2017.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。